|Awarded On||August 21, 2019|
|Title||The Texas Collaborative Center for Hepatocellular Cancer|
|Award Mechanism||Collaborative Action Program to Reduce Liver Cancer Mortality in Texas: Collaborative Action Center|
|Institution/Organization||Baylor College of Medicine|
|Principal Investigator/Program Director||Hashem El-Serag|
|Cancer Sites||Gallbladder, Liver and Intrahepatic Bile Duct|
*Pending contract negotiation
The goal of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) is to reduce liver cancer mortality in Texas by reducing the number of people who develop cancer or detecting it early when it is curable. However, we need more research studies to identify people who are at high risk of liver cancer, to detect liver cancer early, and to turn discoveries into actions doctors and patients can use. This Center will help researchers who study liver cancer work faster and better; team up with other researchers; and share discoveries with doctors, the community, and the general public to change healthcare. We will work with scientists, doctors, healthcare providers, insurers, liver cancer...